CYP cynata therapeutics limited

Ann: Successful Completion of Planned DSMB Review of DFU Trial, page-27

  1. 478 Posts.
    lightbulb Created with Sketch. 114
    That’s kind of why I wish this technology is allowed to develop and flourish as Australian owned, rather than sold off to a random pharma at some point.
    Having unrestricted access to wound healing tech would be a boon to our country and the people that are unlucky enough to get a slow healing wound.
    And that’s just the DFU part, not to mention the other indications the cells can be used for.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.0¢
Change
-0.020(11.8%)
Mkt cap ! $33.89M
Open High Low Value Volume
17.0¢ 18.0¢ 15.0¢ $101.9K 619.3K

Buyers (Bids)

No. Vol. Price($)
7 153571 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 12550 1
View Market Depth
Last trade - 16.10pm 30/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.